Exploratory Efficacy and Safety, Pharmacokinetics and Dose Finding Study of ATryn (Antithrombin Alfa) in Patients With Disseminated Intravascular Coagulation Associated With Severe Sepsis.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Antithrombin alfa (Primary)
- Indications Disseminated intravascular coagulation; Sepsis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 04 Sep 2021 This trial has been completed in Spain, according to European Clinical Trials Database.
- 28 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database record.
- 19 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.